Terminated PHASE4 INTERVENTIONAL 3-arm NCT01233635

Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)

Sponsor: University of Pittsburgh

Interventions continue cozaar no drug start cozaar

Updated 6 times since 2017 Last updated: Mar 22, 2023 Started: Nov 30, 2005 Primary completion: Nov 30, 2007 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

inadequate enrollment rate

Other terminated trials from University of Pittsburgh

See all terminations from University of Pittsburgh

Other Atrial Fibrillation trials with similar outcome

Browse all Atrial Fibrillation trials

Listed as NCT01233635, this PHASE4 trial focuses on Atrial Fibrillation and remains terminated or withdrawn. Sponsored by University of Pittsburgh, it has been updated 6 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Apr 2023 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2021 — Apr 2023 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Pittsburgh

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States